# The Effect of Combined Cryotherapy and Immunotherapy on Systemic T Cell Changes and Clinical Outcomes in Metastatic Non-small Cell Lung Cancer

> **NCT06000358** · NA · UNKNOWN · sponsor: **Lithuanian University of Health Sciences** · enrollment: 120 (estimated)

## Conditions studied

- Lung Cancer Stage IV

## Interventions

- **PROCEDURE:** Bronchoscopic cryotherapy
- **DRUG:** Pembrolizumab
- **DRUG:** Platinum based chemotherapy

## Key facts

- **NCT ID:** NCT06000358
- **Lead sponsor:** Lithuanian University of Health Sciences
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-04-01
- **Primary completion:** 2026-03-31
- **Final completion:** 2026-03-31
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2023-08-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06000358

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06000358, "The Effect of Combined Cryotherapy and Immunotherapy on Systemic T Cell Changes and Clinical Outcomes in Metastatic Non-small Cell Lung Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06000358. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*